pirinixic acid has been researched along with Lung Neoplasms in 3 studies
pirinixic acid: structure
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Wang, W | 1 |
| Dai, M | 1 |
| Li, H | 1 |
| Chen, C | 1 |
| Wang, D | 1 |
| Skrypnyk, N | 1 |
| Chen, X | 1 |
| Hu, W | 1 |
| Su, Y | 1 |
| Mont, S | 1 |
| Yang, S | 1 |
| Gangadhariah, M | 1 |
| Wei, S | 1 |
| Falck, JR | 1 |
| Jat, JL | 1 |
| Zent, R | 1 |
| Capdevila, JH | 1 |
| Pozzi, A | 1 |
| Avis, I | 1 |
| Martínez, A | 1 |
| Tauler, J | 1 |
| Zudaire, E | 1 |
| Mayburd, A | 1 |
| Abu-Ghazaleh, R | 1 |
| Ondrey, F | 1 |
| Mulshine, JL | 1 |
3 other studies available for pirinixic acid and Lung Neoplasms
| Article | Year |
|---|---|
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Prolif | 2019 |
PPARα activation can help prevent and treat non-small cell lung cancer.
Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prol | 2014 |
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Topics: Acetophenones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arachidonic Acid; Caspases | 2005 |